Krystal Biotech
KRYS351.8204.96% ( +16.630 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Krystal Biotech(KRYS) predict that the Revenue is 116.36 M (+31.95%), Beat estimate;the EBIT is 53.69 M (+48.41%), Beat estimate;the EPS is 1.83 (+52.5%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.12B31.95%
0.11B27.16%
+0.00B4.79%
EBITExceed expectations
0.05B48.41%
0.05B25.23%
+0.01B23.18%
EPSExceed expectations
1.8352.50%
1.437519.79%
+0.392532.71%
Upcoming earnings report - FY2026 Q2 Earning Release
Available dateAug 3, 2026
Estimate Revenue122.1 M
Estimate EBIT54.91 M
Estimate EPS1.6655
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf